1. Home
  2. GCT vs ABCL Comparison

GCT vs ABCL Comparison

Compare GCT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GCT

GigaCloud Technology Inc

HOLD

Current Price

$33.37

Market Cap

1.7B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$6.16

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCT
ABCL
Founded
2019
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
GCT
ABCL
Price
$33.37
$6.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$33.00
$8.40
AVG Volume (30 Days)
688.9K
6.0M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
17.70
10.91
EPS
1.04
N/A
Revenue
$1,161,042,000.00
$75,128,000.00
Revenue This Year
$14.43
N/A
Revenue Next Year
$6.78
$21.85
P/E Ratio
$32.03
N/A
Revenue Growth
64.96
160.56
52 Week Low
$19.25
$2.75
52 Week High
$51.82
$6.79

Technical Indicators

Market Signals
Indicator
GCT
ABCL
Relative Strength Index (RSI) 41.46 60.46
Support Level $25.96 $5.23
Resistance Level $34.46 $6.65
Average True Range (ATR) 1.49 0.52
MACD 0.33 -0.01
Stochastic Oscillator 42.45 56.38

Price Performance

Historical Comparison
GCT
ABCL

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: